July 20, 2008
| Bio-IT World > The Right Decision
The Right Decision


By BIO-IT World

The Right Decision

By Melissa Kruse

To create M-FISys, Gene Codes had to put its flagship software product Sequencher on hold for about a year and a half. "It's like dancing with a gorilla," says founder and CEO Howard Cash. "You don't stop when you're tired. You stop when the gorilla is tired. We're not done until the city says we're done."

First released in 1991, Sequencher has become the industry standard for DNA sequencing, and was an important tool in the early stages of the Human Genome Project. Indeed, some of M-FISys was based on Sequencher, but it was mostly built from scratch. The company, which was founded by Cash in 1988, has also created software used by the U.S. Army and the FBI for identifying old war remains and helping the government use DNA samples to identify criminals.

Gene Codes was profitable for 39 consecutive quarters before embarking on M-FISys. Cash set up Gene Codes Forensics Inc., a wholly owned subsidiary of Gene Codes, to create M-FISys, while protecting the rest of the company's assets. Gene Codes signed a three-year, $10-million contract with New York City but will bill for only real hours and expenses — already close to $7 million.

"We made a decision early on not to try to profiteer on this project," Cash says. "We honestly thought we would be working on this for a year at the most." The company will probably see some paper profit eventually, but that will compensate for losses incurred by the pause in Sequencher development. "You don't make money selling software, you make money selling upgrades," Cash says.

Sales manager Carol Carriere says the company "knew it would put a strain on [Sequencher] sales, but the real loss wasn't financial. We lost time for development, and that gave our competitors a chance to catch up."

Even though it will take time before most staff members can refocus their efforts on Sequencher, Cash has no regrets. "If in the process we had brought some comfort to these hundreds and hundreds of families, but in the end we had lost the company, I would still have thought we had made a good investment and the right decision."

Back to Soul Searching




Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

definiens briefingon-76Next-Generation Technologies Revolutionizing Oncology and Diagnostics
underwritten by Definiens

This “Briefing On” collection of Bio-IT World features, commentaries and analysis, presents some of the latest thinking on high-throughput technologies that are being applied to the fields of research and drug discovery, with particular emphasis on oncology, diagnostics and imaging technologies. Download now at no charge compliments of the underwriting sponsor, Definiens. Download This Free Paper



gq nxt gen seq

This Bio•IT World Briefing On “Next-Generation Sequencing,” underwritten by GenomeQuest, Inc.,
presents a selection of feature stories, interviews,commentaries, conference reports, and editorials on the emergence, opportunities, and challenges posed by high-throughput sequencing. Covered in this collection: the launch of new platforms from Applied Biosystems and Helicos; new applications of nextgen sequencing; the rise of personal genomics; and informatics solutions to vexing problem of managing the vast volumes of next-gen data.  Download now 



Life Science Webcasts & Podcasts

GenoLogicsgenologics 2 translational
Enabling Translational Research Informatics

Learn about the challenges facing life sciences research labs to manage their translational research data:

  • The trends for organizations to adopt informatics solutions for translational research.
  • The unique requirements with managing complex data and workflow.
  • What labs should consider when reviewing informatics solutions for translational research.
  • Which life sciences research organizations are successfully adopting an informatics solution.

Download Now



More Podcasts

Job Openings

Assistant Editor (Science Writer)~Cambridge Healthtech Institute (CHI), Needham, MA, 
Cambridge Healthtech Institute seeks an assistant editor (science writer) who is an ambitious, dependable journalist who can fulfill a range of writing and editorial duties for a series of eNewsletters covering various aspects of the biopharmaceutical industry in addition to CHI’s flagship publication, Bio-IT World magazine.  This is a superb opportunity to make important contributions to the growth and success of a multimedia science publishing group, while gaining invaluable experience in multiple facets of the publishing industry.   Interested candidates should submit a cover letter, including 3 writing samples (attached in Word or PDF format), salary history or requirements, and resume to kdavies@healthtech.com. 

Fred Hutchinson Cancer Research Center: IT Business Analyst III
The Hutchinson Center is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest. Through our Tumor Research Initiative, we are finding new ways to detect tumors at an early stage.  We are presently seeking an experienced IT Business Analyst to assess technology needs for the Tumor Research Initiative, and to identify and design improvements to computer based systems.  For more information please visit www.fhcrc.org and search for Job# AD-21465

For reprints and/or copyright permission, please contact RMS, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext 100 or via email to bio-itworld@theygsgroup.com.